Letter from the editor.
作者信息
Metzler-Nolte Nils
机构信息
Chair of Inorganic Chemistry I, Bioinorganic Chemistry, Faculty of Chemistry and Biochemistry, Ruhr University Bochum, Bochum, Germany.
出版信息
J Biol Inorg Chem. 2022 Aug;27(4-5):391-392. doi: 10.1007/s00775-022-01951-6.
Abstract
摘要
相似文献
1
Letter from the editor.编辑来信。
J Biol Inorg Chem. 2022 Aug;27(4-5):391-392. doi: 10.1007/s00775-022-01951-6.
2
Authors' response to letter to the editor, letter to the editor: Authors' response to letter to the editor: Safety concerns with human papilloma virus immunization in Japan: Analysis and evaluation of Nagoya City's surveillance data for adverse events.作者对编辑来信的回复，编辑来信：作者对编辑来信的回复：日本人类乳头瘤病毒免疫接种的安全性问题：名古屋市不良事件监测数据的分析与评估
Jpn J Nurs Sci. 2020 Jan;17(1):e12310. doi: 10.1111/jjns.12310. Epub 2019 Dec 2.
3
How to write an editorial letter?如何撰写编辑信函？
Turk J Urol. 2013 Sep;39(Suppl 1):41-3. doi: 10.5152/tud.2013.053.
4
Letter to the Editor - The implications of the professionalization of health promotion in Canada: a response to JR Graham's letter to the editor.给编辑的信——加拿大健康促进专业化的影响：对 JR Graham 给编辑的信的回应。
Health Promot Chronic Dis Prev Can. 2017 May;37(5):172-173. doi: 10.24095/hpcdp.37.5.05.
5
Letter #1 Response to letter to Editor by Dr. Sarkar et al. for' who said differentiating preeclampsia from COVID-19 infection was easy? Refers to PII: S2210-7789(21)00539-0 Letter #2 Response to letter to Editor by Dr. Hantoushzadeh et al. for' is COVID-19 disease a risk factor for preeclampsia? Should aspirin be considered for prophylaxis of preeclampsia in these patients?' Refers to PII: S2210-7789(21)00538-9.信件1：对Sarkar博士等人致编辑的信的回复，信的主题为“谁说区分先兆子痫和新冠病毒感染很容易？”，涉及编号：S2210 - 7789(21)00539 - 0
信件2：对Hantoushzadeh博士等人致编辑的信的回复，信的主题为“新冠病毒疾病是先兆子痫的危险因素吗？这些患者是否应考虑使用阿司匹林预防先兆子痫？”，涉及编号：S2210 - 7789(21)00538 - 9
Pregnancy Hypertens. 2022 Mar;27:94-95. doi: 10.1016/j.preghy.2021.11.002. Epub 2021 Nov 25.
6
Letter to the Editor Regarding "Editor-in-Chief's April 2021 Letter on 'The Humility Button'".致编辑的信：关于“主编2021年4月关于‘谦逊按钮’的信”
World Neurosurg. 2022 May;161:209-210. doi: 10.1016/j.wneu.2022.02.127.
7
Letter to the Editor Re: Author's Response to Letter to the Editor.致编辑的信：关于作者对致编辑信件的回复
Arch Phys Med Rehabil. 2020 Jun;101(6):1096-1097. doi: 10.1016/j.apmr.2019.12.022. Epub 2020 Mar 7.
8
Response Letter to the Editor in Reference to Letter to the Editor about "Does Overall Catastrophic Health Care Expenditure Make Sense"?针对关于“总体灾难性医疗支出是否合理？”的读者来信给编辑的回复信
Iran J Public Health. 2018 Aug;47(8):1230-1231.
9
How to write a letter to the editor: an author's guide.如何给编辑写信：作者指南
J Chiropr Med. 2006 Winter;5(4):144-7. doi: 10.1016/S0899-3467(07)60147-5.
10
Letter to the Editor Regarding Editor-in-Chief's August 2021 Letter on "Leadership".致编辑的信：关于主编2021年8月关于“领导力”的信
World Neurosurg. 2021 Nov;155:205. doi: 10.1016/j.wneu.2021.08.009.
本文引用的文献
1
A role for bioinorganic chemistry in the reactivation of mutant p53 in cancer.生物无机化学在癌症中突变型 p53 复活中的作用。
J Biol Inorg Chem. 2022 Aug;27(4-5):393-403. doi: 10.1007/s00775-022-01939-2. Epub 2022 Apr 30.
Zotero 插件